What does Enlivex Therapeutics Ltd. do?

Jun 22 2025 07:04 PM IST
share
Share Via
Enlivex Therapeutics Ltd. is an Israel-based clinical-stage company specializing in cell immunotherapy to develop treatments for immune hyper-responses. It has a market cap of $24.57 million and reported a net loss of $3 million in Q1 2025.
Overview:
Enlivex Therapeutics Ltd. is an Israel-based clinical-stage company focused on specialized cell immunotherapy within the Pharmaceuticals & Biotechnology industry, aiming to develop an allogeneic drug pipeline for rebalancing immune hyper-responses.

Financial Snapshot:
Most recent Net Profit: -3 Million (Quarterly Results - Mar 2025)
Market cap: USD 24.57 Million (Micro Cap)

Key Metrics:
P/E: NA (Loss Making)
Industry P/E: NA
Dividend Yield: 0.00%
Debt Equity: -0.99
Return on Equity: -69.45%
Price to Book: 1.19

Contact Details:
Address: 14 Einstein St., NESS-ZIONA None: 7403618
Tel: 972 2 6708072
Fax: 972 2 6708070
Website: https://www.enlivex.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
How big is Enlivex Therapeutics Ltd.?
Jun 22 2025 06:16 PM IST
share
Share Via